Design, synthesis and structure–activity relationship of novel semi-synthetic flavonoids as antiproliferative agents
摘要:
Various flavonoid scaffold based derivatives viz furochalcones (3a-e, 6a-d and 9a-d), furoflavones (10a-d, 11a-d,12a-d,18a&b), flavones (21a-d), furoaurones (13a,b,14a-d and 15a-d) and 7-styrylfurochromones (22a-d and 25a-e) were designed and synthesized. The novel compounds were evaluated for their anti-proliferative activity against a panel of 60 cancer cell lines comprising 9 types of tumors. Ten compounds belonging to the major subgroups of flavonoids viz furochalcones (3a, 3d, 6b, 9a and 9b), furoflavones (12a and 12c), furoaurones (15d), styrylfurochromones (25b and 25e) showed very promising activity. These active compounds were also evaluated in vitro as kinase inhibitors against CDK2/cyclin E1, CDK4/cyclin D1 and GSK-3 beta and the best inhibition was displayed against GSK-3 beta with the allylfurochalcone derivative 9b exhibiting 80% decrease in GSK-3 beta catalytic activity. On the other hand, the styrylfurochromone 25e interestingly showed a 13% enhancement of GSK-3 beta catalytic power and a 12% reduction in CDK4/cyclin D1 activity. Finally, the in vivo anti-tumor activity of 25e was evaluated against breast cancer induced in mice. The results showed a profound anti-tumor effect of 25e that accompanies a significant increase and decrease in the levels of GSK-3 beta and cyclin D1, respectively. (C) 2014 Elsevier Masson SAS. All rights reserved.
Design, synthesis and structure–activity relationship of novel semi-synthetic flavonoids as antiproliferative agents
摘要:
Various flavonoid scaffold based derivatives viz furochalcones (3a-e, 6a-d and 9a-d), furoflavones (10a-d, 11a-d,12a-d,18a&b), flavones (21a-d), furoaurones (13a,b,14a-d and 15a-d) and 7-styrylfurochromones (22a-d and 25a-e) were designed and synthesized. The novel compounds were evaluated for their anti-proliferative activity against a panel of 60 cancer cell lines comprising 9 types of tumors. Ten compounds belonging to the major subgroups of flavonoids viz furochalcones (3a, 3d, 6b, 9a and 9b), furoflavones (12a and 12c), furoaurones (15d), styrylfurochromones (25b and 25e) showed very promising activity. These active compounds were also evaluated in vitro as kinase inhibitors against CDK2/cyclin E1, CDK4/cyclin D1 and GSK-3 beta and the best inhibition was displayed against GSK-3 beta with the allylfurochalcone derivative 9b exhibiting 80% decrease in GSK-3 beta catalytic activity. On the other hand, the styrylfurochromone 25e interestingly showed a 13% enhancement of GSK-3 beta catalytic power and a 12% reduction in CDK4/cyclin D1 activity. Finally, the in vivo anti-tumor activity of 25e was evaluated against breast cancer induced in mice. The results showed a profound anti-tumor effect of 25e that accompanies a significant increase and decrease in the levels of GSK-3 beta and cyclin D1, respectively. (C) 2014 Elsevier Masson SAS. All rights reserved.
Synthesis and reactions of some new benzopyranone derivatives with potential biological activities
作者:El-Sayed I. El-Desoky、Shar S. Al-Shihry
DOI:10.1002/jhet.5570450648
日期:2008.11
to yield the ylidene nicotinonitrile and pyridone derivatives 4,7,10a-b. Reaction of 3 with aniline or aniline acting on multiple function X-H (X = NH, O, S) at its ortho position afforded the corresponding anils, imidazolylfurochromene and azepines compounds 11-17. On the other hand, oxidation of visnagin afforded chromene-6-carboxaldehyde derivative 18 which was condensed with different aryl or (heteroaryl)
Synthesis and reactions of some new allyl furobenzopyranone derivatives
作者:El-Sayed I. El-Desoky
DOI:10.1002/jhet.5570440612
日期:2007.11
Reaction of visnaginone 1 with allyl bromide gave O-allyl visnaginone 2 which underwent Claisen rearrangement to yield 7-allylbenzofuran derivative 3. Reaction of 3 with different aromatic aldehydes gave the corresponding 5-cinnamoylbenzofuran derivatives 4a-d. Condensation of the latter chalcones 4a,c,d with hydrazine hydrate and phenylhydrazine provided, the corresponding pyrazoline derivatives 7a-f